Responses
Pulmonary hypertension
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
Compose a Response to This Article
Other responses
No responses have been published for this article.